Eiko Lifescience

  • Market Cap: Micro Cap
  • Industry: Specialty Chemicals
  • ISIN: INE666Q01016
  • NSEID:
  • BSEID: 540204
INR
50.25
-0.52 (-1.02%)
BSENSE

Dec 05

BSE+NSE Vol: 5.18 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'25
Mar'20
Mar'19
Mar'18
Net Sales
37.66
10.35
4.25
2.34
Other Operating Income
0.00
0.00
0.00
0.00
Total Operating income
37.66
10.35
4.25
2.34
Raw Material Cost
35.04
7.85
2.42
0.76
Purchase of Finished goods
0.00
0.00
0.00
0.47
(Increase) / Decrease In Stocks
-2.38
-0.24
0.65
0.15
Employee Cost
0.37
2.64
0.78
0.18
Power Cost
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.01
0.00
0.43
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
Other Expenses
1.87
4.65
1.11
-0.00
Total Expenditure (Excl Depreciation)
34.90
14.91
4.96
1.99
Operating Profit (PBDIT) excl Other Income
2.76
-4.56
-0.71
0.35
Other Income
0.72
0.06
0.06
0.07
Operating Profit (PBDIT)
3.48
-4.50
-0.65
0.41
Interest
0.16
0.24
0.17
0.08
Exceptional Items
0.34
0.00
0.00
0.00
Gross Profit (PBDT)
3.66
-4.74
-0.82
0.33
Depreciation
0.74
0.19
0.17
0.08
Profit Before Tax
2.92
-4.93
-1.00
0.25
Tax
0.75
-1.31
-0.21
0.05
Provisions and contingencies
0.00
0.00
0.00
0.00
Profit After Tax
2.18
-3.62
-0.78
0.20
Extraordinary Items
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
Net Profit
2.18
-3.62
-0.78
0.20
Share in Profit of Associates
0.14
0.00
0.00
0.00
Minority Interest
-0.21
1.71
0.34
0.00
Other related items
0.00
0.00
0.00
0.00
Consolidated Net Profit
2.11
-1.91
-0.44
0.20
Equity Capital
13.76
3.82
3.82
3.82
Face Value
10.0
10.0
10.0
10.0
Reserves
0.00
-0.87
1.10
0.00
Earnings per share (EPS)
1.53
-5.0
-1.15
0.51
Diluted Earnings per share
1.62
-4.99
-1.16
0.63
Operating Profit Margin (Excl OI)
7.33%
-44.06%
-16.71%
14.89%
Gross Profit Margin
9.72%
-45.8%
-19.29%
14.04%
PAT Margin
5.79%
-34.98%
-18.35%
8.6%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Markets Mojo
Analysis not available as Data has been published for only 1 period
Compare Annual Results Of Eiko Lifescience With
Markets Mojo
Figures in Cr
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
37.66
193.93
-156.27
-80.58%
Other Operating Income
0.00
0.00
0.00
Total Operating income
37.66
193.93
-156.27
-80.58%
Raw Material Cost
35.04
156.99
-121.95
-77.68%
Purchase of Finished goods
0.00
0.00
0.00
(Increase) / Decrease In Stocks
-2.38
-10.61
8.23
77.57%
Employee Cost
0.37
7.69
-7.32
-95.19%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
1.87
29.06
-27.19
-93.57%
Total Expenditure (Excl Depreciation)
34.90
183.13
-148.23
-80.94%
Operating Profit (PBDIT) excl Other Income
2.76
10.80
-8.04
-74.44%
Other Income
0.72
0.00
0.72
Operating Profit (PBDIT)
3.48
10.80
-7.32
-67.78%
Interest
0.16
7.78
-7.62
-97.94%
Exceptional Items
0.34
0.00
0.34
Gross Profit (PBDT)
3.66
3.02
0.64
21.19%
Depreciation
0.74
3.08
-2.34
-75.97%
Profit Before Tax
2.92
-0.06
2.98
4,966.67%
Tax
0.75
1.29
-0.54
-41.86%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
2.18
-1.34
3.52
262.69%
Extraordinary Items
0.00
0.49
-0.49
-100.00%
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
2.18
-0.85
3.03
356.47%
Share in Profit of Associates
0.14
0.00
0.14
Minority Interest
-0.21
0.00
-0.21
Other related items
0.00
0.00
0.00
Consolidated Net Profit
2.11
-0.85
2.96
348.24%
Equity Capital
13.76
7.66
6.10
79.63%
Face Value
10.00
10.00
0.00
Reserves
0.00
40.69
-40.69
-100.00%
Earnings per share (EPS)
1.53
-1.11
2.64
237.84%
Diluted Earnings per share
1.62
-2.11
3.73
176.78%
Operating Profit Margin (Excl OI)
7.33%
5.61%
0.00
1.72%
Gross Profit Margin
9.72%
1.57%
0.00
8.15%
PAT Margin
5.79%
-0.70%
0.00
6.49%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 37.66 Cr
in Mar 2025

Figures in Cr
stock-summary

Annual - Consolidate Net Profit
Consolidate Net Profit 2.11 Cr
in Mar 2025

Figures in Cr
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 2.76 Cr
in Mar 2025

Figures in Cr
Annual - Interest
Interest 0.16 Cr
in Mar 2025

Figures in Cr
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 7.33%
in Mar 2025

Figures in %